- English
- Faranse
- Jẹmánì
- Portuguese
- Sipeeni
- Russian
- Japanese
- Korean
- Larubawa
- Irish
- Giriki
- Tọki
- Itali
- Danish
- Romanian
- Ede Indonesian
- Czech
- Afrikaans
- Swedish
- pólándì
- Basque
- Catalan
- Esperanto
- Hindi
- Lao
- Ede Albania
- Amharic
- Ara Armenia
- Azerbaijan
- Belarusian
- Ede Bengali
- Ede Bosnia
- Bulgarian
- Cebuano
- Chichewa
- Corsican
- Ede Croatian
- Dutch
- Estonia
- Filipino
- Finnish
- Frisia
- Galician
- Georgian
- Gujarati
- Ede Haiti
- Hausa
- Ilu Hawahi
- Heberu
- Hmong
- Ede Hungarian
- Icelandic
- Igbo
- Javanese
- Kannada
- Kazakh
- Khmer
- Kurdish
- Kirgisi
- Latin
- Latvia
- Lithuania
- Lithuania
- Macedonian
- Malagasy
- Malay
- Malayalam
- Èdè Malta
- Maori
- Marathi
- Mongolian
- Burmese
- Nepali
- Norwegian
- Pashto
- Persian
- Punjabi
- Ede Serbia
- Sesotho
- Sinhala
- Slovakia
- Slovenia
- Somali
- Samoan
- Scotland Gaelic
- Shona
- Sindhi
- Ede Sundan
- Swahili
- Tajik
- Tamil
- Telugu
- Thai
- Ukrainian
- Urdu
- Uzbekisi
- Vietnamese
- Welsh
- Xosa
- Yiddish
- Yoruba
- Zulu
- Kinyarwanda
- Tatar
- Oriya
- Turkmen
- Uyghur
Ọja Series
Ohun elo Wiwa Troponin I ti o ni imọra (Akoko-Ipinnu Fluorescence Imunoassay Quantitative Gbẹ)
ṢEWỌRỌ
Ohun elo Iwari Antibody IgG kan-ounjẹ (Aṣeyẹwo Imunosorbent ti sopọ mọ Enzyme)
ṢEWỌRỌ
Apo Iwari Haemoglobin Glycated
Àtọgbẹ jẹ ọkan ninu awọn ajakale-arun ti o wọpọ julọ ni agbaye. Iwadi NCBI (2016) fihan pe a nireti pe àtọgbẹ jẹ idi pataki keje ti iku nipasẹ 2030. Gẹgẹbi International Diabetes Federation (IDF), ni 2017, diẹ sii ju 12 million c
ṢEWỌRỌ
Amuaradagba Isopọ Heparin
Ti tẹlẹ: COVID-19 Idanwo Antijeni Rapid Next:
ṢEWỌRỌ
NIPA RE
Ti a da ni Oṣu Keji ọdun 2010, Joinstar Biomedical Technology Co., Ltd. (lẹhin ti a tọka si Joinstar) jẹ ile-iṣẹ imọ-ẹrọ giga ti orilẹ-ede ti o ṣe amọja ni R&D, iṣelọpọ, ati titaja ti awọn ọja iwadii in vitro (IVD). Ni afikun, o ni
Duro Ni Fọwọkan
Forukọsilẹ fun iwe iroyin wa lati gba awọn iroyin ọja ti a ṣe adani, awọn imudojuiwọn ati awọn ifiwepe pataki.